Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

At AAD 2025, five-year data for BIMZELX® (bimekizumab-bkzx) demonstrated sustained skin clearance and long-term efficacy in moderate-to-severe plaque psoriasis

sustained clinical benefits across different adult patient populations living with this common inflammatory skin condition.1-4 "A primary treatment goal for people living with psoriasis is durable, high rates of complete skin clearance. These...

MedaSystems secures additional seed financing to advance its AI-driven workflow platform, expanding access and supporting investigator-initiated studies

MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva...

Newly-formed Archerfish Precision Diagnostics Pte Ltd ushers in a new era in advanced diagnostics

In a significant development for the clinical diagnostics landscape in Singapore, Angsana Molecular & Diagnostics Laboratory (Angsana) and Pathnova Laboratories (Pathnova) have announced their merger to form Archerfish Precision Diagnostics...

Shorla Oncology Announces the Launch of Dedicated Sales Force and Market Access Teams as Part of Expansion of Its U.S. Commercial Footprint

to provide necessary treatment options to patients with cancer.” In 2024, an estimated 9,280 people were diagnosed with CML1, over 10,000 with MDS/MPD2, and up to 6,000 with GIST3 in the U.S. Despite the proven clinical benefits of imatinib,...

"Latigo Biotherapeutics has been granted FDA Fast Track Designation for LTG-001, a potential best-in-class Nav1.8 inhibitor for the non-opioid treatment of acute pain

("Latigo") announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to LTG-001, the company's oral, investigational selective Nav1.8 inhibitor for the treatment of acute pain. LTG-001 works by blocking...

Dr. Scott Grady Makes Thyroid RFA More Accessible in Oregon

lasting 30–60 minutes, depending on the size of the nodule. Patients remain under observation for an additional 60–120 minutes before discharge. Dr. Grady uses STARmed's industry-leading RF technology to ensure the highest standard of care with the...

TOOsonix Partners with MikronMed to Introduce Innovative Dermatological Therapy in the Nordic Region

TOOsonix A/S, a leader in high-intensity focused ultrasound technology for dermatology, has partnered with MikronMed AB, a top distributor of medical equipment in the Nordic region. The collaboration will bring TOOsonix innovative MDR CE marked...

Cellino Launches the U.S.’s First Nebula-Powered iPSC Foundry for Scalable Autologous Biomanufacturing

Neurosurgeon Jeffrey Schweitzer, M.D., Ph.D., the George A. Lopez, MD Endowed Chair in Neurosurgery, is leading a Phase 1 trial at Mass General Brigham. “Using a patient’s own cells as a starting point has clear advantages such as minimizing...

Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing

biotherapeutics, announced the appointment of Ashley Scholz as Vice President of Marketing. Ashley brings over 16 years of experience in marketing leadership within the medical device, cancer diagnostics, and molecular diagnostics industries. In...

LabConnect and Australian Clinical Labs' Specialised Trials Announce a Strategic Partnership in the Australia and Asia Pacific Region

the leading clinical trials laboratories in Australia, managing large biotech and pharmaceutical clinical trials from Phase 1 to Phase 4 studies. With a vast network of laboratories across Australia, ACL Specialised Trials has extensive experience...

Regemat 3D to Distribute VitroInk® Bioinks in Europe: A Strategic Move for Advanced Bioprinting Solutions

with Regemat 3D's mission to provide state-of-the-art bioprinting solutions. Regemat 3D has grown to become one of the top 15 3D bioprinting emerging companies worldwide, with a presence in more than 30 countries and collaborators in over 100...

A convenient and cost-effective way to treat sickle cell disease may be offered by Vascarta's patented transdermal drug candidate

studies in which humanized sickle cell mice topically treated with Vascarta's transdermal curcumin gel formulation ("VAS-101") experienced reduced pain and inflammation along with improved red blood cell stability and functionality. Based in part...

MAYPHARM CO., LTD. launches SKINCOLLA, the world's first recombinant human collagen filler for superior skin rejuvenation

skin. Revolutionizing Collagen Filler Technology SKINCOLLA is a game-changer in aesthetic treatments. It combines 100% human-identical recombinant collagen with Hyaluronic Acid (HA), providing immediate and lasting improvements to skin texture,...

Fosun Pharma deeply embraces AI, with its self-developed PharmAID Decision Intelligence Platform boosting efficient innovation

PharmAID Decision Intelligence Platform Integrates Global Leading Large Model Technology and Has connected with Deepseek R1 As a pioneer in the AI transformation of the pharmaceutical industry, Fosun Pharma recently launched its self-developed...

"Grindeks, the leading pharmaceutical company in the Baltics, expands to new export markets worldwide

strategic approach and its ability to adapt and succeed in dynamic market conditions. With a vision to rank among the top 100 pharmaceutical companies globally, Grindeks continues to drive innovation, expand its reach, and strengthen its...

Fresenius Kabi Launches Calcitonin Salmon Injection, USP Synthetic

Verma, president of Fresenius Kabi Region U.S. and member of the executive leadership team at Fresenius Kabi AG. Since 2017, Fresenius Kabi has invested nearly $1 billion to modernize and expand its advanced U.S. pharmaceutical production and...

Marius Pharmaceuticals Expands Men's Health Solutions by Announcing the Availability of KYZATREX® (testosterone undecanoate) CIII Capsules Through Thrive

The safety and efficacy of KYZATREX was demonstrated in a phase 3, multi-center, open-label, six-month study in 155 hypogonadal males between 18 and 65 years of age with documented hypogonadism, as defined by a below normal serum testosterone level...

Centinel Spine's Match-the-Disc™ prodisc® Cervical Total Disc Replacement System has completed over 10,000 procedures in the U.S

clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), announced the completion of the 10,000th case in the U.S. with the Match-the-Disc™ prodisc Cervical TDR System. The new Match-the-Disc prodisc Cervical TDR...

Jabil acquires Pharmaceutics International, Inc

Global Business Units, Healthcare, at Jabil. Jabil is a leader in parenteral drug delivery, in support of markets like GLP-1s. This acquisition will significantly enhance Jabil’s existing Pharmaceutical Solutions offering, which includes the...

Zafrens expands its investor syndicate to scale its revolutionary drug discovery platform

transforming drug discovery, welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand is joined by existing investors Prime Movers Lab, Kofa Healthcare, and Global Brain in this financing....